Clinical Trial Update: Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus [Phase 2]

View source ↗

Summary

SRD174 Cream completed a Phase IIa safety and efficacy trial in patients with atopic dermatitis-associated pruritus. The study evaluated safety and preliminary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SRD174 Cream

Snippet

Sponsor: Serentis Ltd. | Conditions: Pruritus, Atopic Dermatitis | Phase 2 | Status: COMPLETED